The Canadian Clinical Drug Data Set April 2025 release is now available for access and implementation on the Terminology Server and Terminology Gateway.
Learn More >
Important Update: We are pleased to announce significant enhancements to our FHIR Terminology Server, offering more seamless and standards-based access to terminology content for healthcare data exchange. Discover the new features and upcoming changes to our Terminology Gateway.
Learn More >
We are going to cancel our Medications & Immunizations weekly calls and will consider setting up a review meeting if we get any feedback that needs to be discussed on a call.
One outstanding question is whether there is a need to create a new extension to represent a 'DPD Company' name (as opposed to the existing 'manufacturer' element) for both Medication and Immunization profiles.
A 'DPD Company' name, as used in the Health Canada DPF, indicates the organisation (company) that holds the authorization to place the product on the market in Canada. This may not be the company that has manufactured the product, but it is the company that holds the legal responsibility for the use of the product in Canada and should be the same as the company named on the product label/packaging.
Improving the quality of patient care through the effective sharing of clinical information among health care organizations, clinicians and their patients.
Medications and Immunizations Draft Profiles are Complete and Ready for Review
Print
Email
Twitter